Post

Pfizer’s weight loss drug hits primary endpoint in Phase IIb trial

Pfizer has announced that its Phase IIb trial investigating oral weight loss drug danuglipron has met its primary endpoint. The glucagon-like …

The movement towards trial transparency

Transparency throughout the entire clinical trial industry was a persistent theme at the tenth annual Outsourcing in Clinical Trials DACH …

BlueSkeye AI to begin trial of AI mental health app for perinatal depression

The Medical and Healthcare products Regulatory Agency (MHRA) has greenlit BlueSkeye AI to begin a clinical trial investigating its TrueBlue …

World AIDS Day 2023 highlights community leadership to end the HIV epidemic

1 December commemorates World AIDS Day – a day of awareness and support for those living with HIV/AIDS, as well …

SciNeuro concludes dosing in study of Alzheimer’s therapeutic

SciNeuro Pharmaceuticals has concluded subject dosing in the Phase I clinical study of its oral therapeutic candidate, SNP318, to treat …